Antibiotics for treating acute chest syndrome in people with sickle cell disease

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 3, 2015, Pages

  Martí Carvajal, Arturo J ^a   Conterno, Lucieni O ^b   Knight Madden, Jennifer M ^c  

^a Iberoamerican Cochrane Network   (Venezuela)

^b Marilia Medical School   (Brazil)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NARCOTIC ANALGESIC AGENT; PLACEBO; ANTIINFECTIVE AGENT;

ACUTE CHEST SYNDROME; ADVERSE DRUG REACTION; ADVERSE EVENT; AGE; ANTIBIOTIC THERAPY; ASSISTED VENTILATION; CAUSE OF DEATH; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; GEOGRAPHY; HUMAN; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; RESPIRATORY FAILURE; REVIEW; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; TREATMENT DURATION; ANOXIA; COUGH; FEVER; MICROBIOLOGY; SECRETION (PROCESS); SPUTUM;

ACUTE CHEST SYNDROME; ANOXIA; ANTI-BACTERIAL AGENTS; COUGH; FEVER; HUMANS; SPUTUM;

EID: 84942805970     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006110.pub4     Document Type: Review

References (89)

1. Alabdulaali MK. Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes. Annals of Thoracic Medicine 2007;2:158-62.
2. Alderson P, Roberts I. Should journals publish systematic reviews that find no evidence to guide practice? Examples from injury research. BMJ 2000;320(7231):376-7.
3. Aslan M, Freeman BA. Redox-dependent impairment of vascular function in sickle cell disease. Free Radical Biology & Medicine 2007;43:1469-83.
4. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [PUBMED: 21208779]
5. Barrett-Connor E. Acute pulmonary disease and sickle cell anemia. The American Review of Respiratory Disease 1971;104:159-65.
6. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971;50:97-112.
7. Basch E, Aronson N, Berg A, Flum D, Gabriel S, Goodman SN, et al. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA 2012;307(15):1636-40.
8. Benza RL. Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment. Lung 2008;186:247-54.
9. Bonds DR. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Review 2005;19:99-110.
10. Boyd JH, Moinuddin A, Strunk RC, DeBaun MR. Asthma and acute chest in sickle-cell disease. Pediatric Pulmonology 2004;38:229-32.
11. Buchanan ID, Woodward M, Reed GW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatric Blood & Cancer 2005;45:716-24.
12. Bunn HF. Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine 1997;337:762-9.
13. Chalmers I. Well informed uncertainties about the effects of treatments. How clinicians and patients respond?. BMJ 2004;328(7438):475-6.
14. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586.
15. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Annals of Internal Medicine 2013;158(3):200-7.
16. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Archives of Internal Medicine 1979;139:67-9.
17. Davies SC, Luce PJ, Win AA, Riordan JF, Brozovic M. Acute chest syndrome in sickle-cell disease. Lancet 1984;323(8367):36-8.
18. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, et al. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. Journal of Pediatric Hematology/Oncology 2003;25(1):46-55.
19. Delatte SJ, Hebra A, Tagge EP, Jackson S, Jacques K, Othersen HB Jr. Acute chest syndrome in the postoperative sickle cell patient. Journal of Pediatric Surgery 1999;34:188-91.
20. Duckworth L, Hsu L, Feng H, Wang J, Sylvester JE, Kissoon N, et al. Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatric Pulmonology 2007;42:332-8.
21. Fauroux B, Tamalet A, Desmarquest P, Clement A. Pathophysiology of acute thoracic syndrome. Pathologie-biologie 1999;47:26-30.
22. Gabriel SE, Normand SL. Getting the Methods Right - The Foundation of Patient-Centered Outcomes Research. New England Journal of Medicine 2012;367(9):787-90. [PUBMED: 22830434]
23. Brozek J, Oxman A, Schünemann H. GRADEpro. 3.2 for Windows. McMaster University, 2008.
24. Gurusamy KS, Gluud C, Nikolova D, Davidson BR. Assessment of risk of bias in randomized clinical trials in surgery. The British Journal of Surgery 2009;96:342-9.
25. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93.
26. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294-302.
27. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence--publication bias. Journal of Clinical Epidemiology 2011;64(12):1277-82.
28. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10.
29. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311-6.
30. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15.
31. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
32. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380-2.
33. Hagar W, Vichinsky E. Advances in clinical research in sickle cell disease. British Journal of Haematology 2008;141:346-56.
34. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
35. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
36. Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781-8.
37. Ioannidis JP. Why most discovered true associations are inflated. Epidemiology 2008;19:640-8.
38. Ioannidis JP. Perfect study, poor evidence: interpretation of biases preceding study design. Seminars in Hematology 2008;45:160-6.
39. Jaiyesimi O, Kasem M. Acute chest syndrome in Omani children with sickle cell disease: epidemiology and clinical profile. Annals of Tropical Paediatrics 2007;27:193-9.
40. Johnson CS. The acute chest syndrome. Hematology/Oncology Clinics of North America 2005;19(5):857-79.
41. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews 2007;21:37-47.
42. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. American Journal of Hematology 2009;84:618-25.
43. Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG 6th, Hazen SL. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology 2009;145:506-13.
44. Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respiratory Research 2001;2:280-5.
45. Knight J, Murphy TM, Browning I. The lung in sickle cell disease. Pediatric Pulmonology 1999;28:205-16.
46. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60:206-10.
47. Kokoska ER, West KW, Carney DE, Engum SE, Heiny ME, Rescorla FJ. Risk factors for acute chest syndrome in children with sickle cell disease undergoing abdominal surgery. Journal of Pediatric Surgery 2004;39:848-50.
48. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clinical Pharmacology and Therapeutics 2004;75(3):140-6.
49. Lee WL, Slutsky AS. Hypoxemic Respiratory Failure, Including Acute Respiratory Distress Syndrome. Murray & Nadel's Textbook of Respiratory Medicine. Saunders, 2005.
50. Lonergan GJ, Cline DB, Abbondanzo SL. Sickle cell anemia. Radiographics 2001;21:971-94.
51. Lottenberg R, Hassell KL. An evidence-based approach to the treatment of adults with sickle cell disease. Hematology / The Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2005:58-65.
52. Lowenthal EA, Wells A, Emanuel PD, Player R, Prchal JT. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review. American Journal of Hematology 1996;51:207-13.
53. Mack AK, Kato GJ. Sickle cell disease and nitric oxide: a paradigm shift?. The International Journal of Biochemistry & Cell Biology 2006;38:1237-43.
54. Mahdi N, Al-Subaie AM, Al-Ola K, Al-Irhayim AQ, Ali ME, Al-Irhayim Z, et al. HLA DRB1*130101-DQB1*060101 haplotype is associated with acute chest syndrome in sickle cell anemia patients. Tissue Antigens 2009;73:245-9.
55. Mankad VN. Exciting new treatment approaches for pathophysiologic mechanisms of sickle cell disease. Pediatric Pathology & Molecular Medicine 2001;20:1-13.
56. Mekontso Dessap A, Leon R, Habibi A, Nzouakou R, Roudot-Thoraval F, Adnot S, et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. American Journal of Respiratory and Critical Care Medicine 2008;177:646-53.
57. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology 2010;63(8):e1-37. [PUBMED: 20346624]
58. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology / the Education Program of the American Society of Hematology. Philadelphia: American Society of Hematology, 2008:177-85.
59. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Annals of Internal Medicine 2004;140:795-801.
60. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics 2003;112(1 Pt 1):87-95.
61. Nordness ME, Lynn J, Zacharisen MC, Scott PJ, Kelly KJ. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clinical and molecular allergy: CMA [electronic resource] 2005; Vol. 3:2.
62. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949;110:543-6.
63. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine 1994;330:1639-44.
64. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. Journal of Pediatrics 1985;107:861-6.
65. Quinn CT, Buchanan GR. The acute chest syndrome of sickle cell disease. Journal of Pediatrics 1999;135:416-22.
66. Salzman SH. Does splinting from thoracic bone ischemia and infarction contribute to the acute chest syndrome in sickle cell disease?. Chest 2002;122:6-9.
67. Saunthararajah Y, Vichinsky EP, Embury SH. Sickle cell disease. Hoffman: Hematology: Basic Principles and Practice. Churchill Livingstone, 2004.
68. Serarslan G, Akgül F, Babayigit C. High prevalence of pulmonary hypertension in homozygous sickle cell patients with leg ulceration. Clinical and Experimental Hypertension 2009;31:44-8.
69. Siddiqui AK, Ahmed S. Pulmonary manifestations of sickle cell disease. Postgraduate Medical Journal 2003;79(933):384-90.
70. Sylvester KP, Patey RA, Broughton S, Rafferty GF, Rees D, Thein SL, et al. Temporal relationship of asthma to acute chest syndrome in sickle cell disease. Pediatric Pulmonology 2007;42:103-6.
71. Steinberg MH. Genetic etiologies for phenotypic diversity in sickle cell anemia. The Scientific World Journal 2009;9:46-67.
72. Strouse JJ, Takemoto CM, Keefer JR, Kato GJ, Casella JF. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatric Blood & Cancer 2008;50:1006-12.
73. Suara RO. Group A beta-haemolytic streptococcal acute chest event in a child with sickle cell anaemia. Annals of Tropical Paediatrics 2001;21:175-8.
74. Suell MN, Bezold LI, Okcu MF, Mahoney DH Jr, Shardonofsky F, Mueller BU. Increased pulmonary artery pressures among adolescents with sickle cell disease. Journal of Pediatric Hematology/Oncology 2005;27:654-58.
75. Sullivan KJ, Kissoon N, Gauger C. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia. Pediatric Critical Care Medicine 2008;9:159-68.
76. Sylvester KP, Patey RA, Milligan P, Rafferty GF, Broughton S, Rees D, et al. Impact of acute chest syndrome on lung function of children with sickle cell disease. Journal of Pediatrics 2006;149:17-22.
77. Taylor C, Carter F, Poulose J, Rolle S, Babu S, Crichlow S. Clinical presentation of acute chest syndrome in sickle cell disease. Postgraduate Medical Journal 2004;80:346-9.
78. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.MR000030.pub2]
79. van Agtmael MA, Cheng JD, Nossent HC. Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease. Analysis of 81 episodes among 53 patients. Archives of Internal Medicine 1994;154:557-61.
80. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal Medicine 2000;342:1855-65.
81. Wales PW, Carver E, Crawford MW, Kim PC. Acute chest syndrome after abdominal surgery in children with sickle cell disease: Is a laparoscopic approach better?. Journal of Pediatric Surgery 2001;36(5):718-21.
82. Wang WC. Unstable Hemoglobin Disease. In: Greer JP, Foerster J, Lukens JN, Rogers GM, Frixos P, Glader BE editor(s). Wintrobe's Clinical Hematology. 11th Edition. Lippincott Williams & Wilkins, 2003.
83. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited Disorders of Hemoglobin. Disease Control Priorities in Developing Countries. 2nd Edition. Washington DC: The World Bank and Oxford University Press, 2006.
84. Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001;357(9257):680-3.
85. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biology and Medicine 2008;44:1506-28.
86. Young RC Jr, Rachal RE, Hackney RL Jr, Uy CG, Scott RB. Smoking is a factor in causing acute chest syndrome in sickle cell anemia. Journal of the National Medical Association 1992;84:267-71.
87. Zavala D, Martí A, Peña-Martí G, Comunián G. Sheet to enter data for performing a Cochrane review. 1. Valencia, Venezuela: Universidad de Carabobo, 2006.
88. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006110.pub2; MEDLINE: 17443613]
89. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD006110.pub3]